$450M Fraud Acquittal: United States vs. Bothra
SHG Healthcare’s Key Role in the Defense Victory of United States v. Bothra: Leveraging Statistical Evidence to Rebut Healthcare Fraud […]
Blog
$1M in Medicaid Fraud Charges Dismissed
SHG Healthcare’s Investigation Leads to Dismissal of Medicaid Fraud Charges Medicaid Fraud Charges Dismissed After a diligent investigation, federal prosecutors
FDA’s Overreach on Compounded Peptides: Legal Battles and How Clinics Can Push Back
Introduction: Peptide therapies like BPC-157, TB-500 (Thymosin Beta-4), CJC-1295, and other short proteins have exploded in popularity across med spas,
WOUND CARE UPDATE: CY 2026 Medicare Physician Fee Schedule Final Rule (CMS1832F)
Published November 5, 2025 • Effective January 1, 2026 This update explains the new Medicare rule in clear terms and
CMS Withdraws Final Skin Substitute LCDs; 2026 Oversight and Payment Reforms Remain the Operative Risk Environment
CMS has announced that its A/B Medicare Administrative Contractors (MACs) have withdrawn, effective immediately, the “final” Local Coverage Determinations (LCDs)
M in Medicaid Fraud Charges Dismissed
SHG Healthcare’s Investigation Leads to Dismissal of Medicaid Fraud Charges Medicaid Fraud Charges Dismissed After a diligent investigation, federal prosecutors
Charges Dismissed Against Whistleblower Physician — A Victory for Transparency and a Reminder on HIPAA Compliance
The U.S. Department of Justice (DOJ) dismissed all charges against Dr. Eithan Haim, who blew the whistle on pediatric transgender
Chapman Predicts Stark Infested Waters For 2025
By Ronald W. Chapman II As a lawyer who has defended healthcare professionals across the country, I’ve seen firsthand how
SHG President & Founder Discusses Red Flags and Healthcare Compliance
SHG Healthcare President Ronald Chapman II discusses DEA Red Flags and compliance investigations for healthcare providers with Mark Garofoli on a recent episode
